UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis

Journal of neuroimmunology, 2019-04, Vol.329, p.24-34

2019

Volltextzugriff (PDF)

Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis

Brain (London, England : 1878), 2009-01, Vol.132 (1), p.239-249

2009

Volltextzugriff (PDF)

Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis

Multiple sclerosis, 2010-11, Vol.16 (11), p.1349-1359

2010

Volltextzugriff (PDF)

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

Lancet neurology, 2008-09, Vol.7 (9), p.796-804

2008

Volltextzugriff (PDF)

MOG-IgG-associated demyelination: focus on atypical features, brain histopathology and concomitant autoimmunity

Journal of neurology, 2020-02, Vol.267 (2), p.359-368

2020

Volltextzugriff (PDF)

Are current disease‐modifying therapeutics in multiple sclerosis justified on the basis of studies in experimental autoimmune encephalomyelitis

Journal of neurochemistry, 2010-11, Vol.115 (4), p.829-844

2010

Volltextzugriff (PDF)

Fatigue in multiple sclerosis — A brief review

Journal of the neurological sciences, 2012-12, Vol.323 (1), p.9-15

2012

Volltextzugriff (PDF)

Investigating the Effect of Cigarette Smoking on Serum Uric Acid Levels in Multiple Sclerosis Patients: A Cross Sectional Study

Brain sciences, 2023-05, Vol.13 (5), p.800

2023

Volltextzugriff (PDF)

A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic

Multiple sclerosis, 2004-10, Vol.10 (5), p.575-581

2004

Volltextzugriff (PDF)

Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2008-04, Vol.79 (4), p.437-441

2008

Volltextzugriff (PDF)

Investigating Microstructural Changes in White Matter in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Neurite Orientation Dispersion and Density Imaging

Brain sciences, 2021-08, Vol.11 (9), p.1151

2021

Volltextzugriff (PDF)

Maintenance Intravenous Immunoglobulin Treatment for Multiple Sclerosis Coexisting with Ehlers-Danlos Syndrome and Muir-Torre Syndrome: A Case Study

Neurology and therapy, 2020-12, Vol.9 (2), p.605-610

2020

Volltextzugriff (PDF)

Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis

Neurology and therapy, 2019-06, Vol.8 (1), p.45-57

2019

Volltextzugriff (PDF)

Neurological Disorders Associated With COVID-19 Hospital Admissions: Experience of a Single Tertiary Healthcare Center

Frontiers in neurology, 2021-02, Vol.12, p.640017-640017

2021

Volltextzugriff (PDF)

Easy to interpret coordinate based meta-analysis of neuroimaging studies: Analysis of brain coordinates (ABC)

Journal of neuroscience methods, 2022-04, Vol.372, p.109556-109556, Article 109556

2022

Volltextzugriff (PDF)

Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells

Neurology and therapy, 2023-12, Vol.12 (6), p.2041-2052

2023

Volltextzugriff (PDF)

Plasma endocannabinoid levels in multiple sclerosis

Journal of the neurological sciences, 2009-12, Vol.287 (1), p.212-215

2009

Volltextzugriff (PDF)

Investigating Brain Microstructural Alterations in Type 1 and Type 2 Diabetes Using Diffusion Tensor Imaging: A Systematic Review

Brain sciences, 2021-01, Vol.11 (2), p.140

2021

Volltextzugriff (PDF)

Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

Lancet neurology, 2010-07, Vol.9 (7), p.672-680

2010

Volltextzugriff (PDF)

Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios

Journal of neurology, neurosurgery and psychiatry, 2016-03, Vol.87 (3), p.324-331

2016

Volltextzugriff (PDF)

Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis

Neurology : neuroimmunology & neuroinflammation, 2015-08, Vol.2 (4), p.e117-e117

2015

Volltextzugriff (PDF)

Natalizumab Treatment for Relapsing Multiple Sclerosis Stabilises Normal-Appearing White Matter Microstructure: A One-Year Prospective Ultra-High-Field Quantitative Imaging Study

Brain sciences, 2023-10, Vol.13 (10), p.1464

2023

Volltextzugriff (PDF)

Validation of the Multiple Sclerosis International Quality of Life questionnaire

Multiple sclerosis, 2008-03, Vol.14 (2), p.219-230

2008

Volltextzugriff (PDF)

Delirium as a presenting feature in COVID-19: Neuroinvasive infection or autoimmune encephalopathy?

Brain, behavior, and immunity, 2020-08, Vol.88, p.68-70

2020

Volltextzugriff (PDF)

Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis

Journal of neurovirology, 2017-12, Vol.23 (6), p.839-844

2017

Volltextzugriff (PDF)

1 – 25 von 246

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences & Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(202)

Publikationsform

Artikel
(245)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis

Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis

Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

MOG-IgG-associated demyelination: focus on atypical features, brain histopathology and concomitant autoimmunity

Are current disease‐modifying therapeutics in multiple sclerosis justified on the basis of studies in experimental autoimmune encephalomyelitis

Fatigue in multiple sclerosis — A brief review

Investigating the Effect of Cigarette Smoking on Serum Uric Acid Levels in Multiple Sclerosis Patients: A Cross Sectional Study

A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic

Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis

Investigating Microstructural Changes in White Matter in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Neurite Orientation Dispersion and Density Imaging

Maintenance Intravenous Immunoglobulin Treatment for Multiple Sclerosis Coexisting with Ehlers-Danlos Syndrome and Muir-Torre Syndrome: A Case Study

Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis

Neurological Disorders Associated With COVID-19 Hospital Admissions: Experience of a Single Tertiary Healthcare Center

Easy to interpret coordinate based meta-analysis of neuroimaging studies: Analysis of brain coordinates (ABC)

Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells

Plasma endocannabinoid levels in multiple sclerosis

Investigating Brain Microstructural Alterations in Type 1 and Type 2 Diabetes Using Diffusion Tensor Imaging: A Systematic Review

Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios

Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis

Natalizumab Treatment for Relapsing Multiple Sclerosis Stabilises Normal-Appearing White Matter Microstructure: A One-Year Prospective Ultra-High-Field Quantitative Imaging Study

Validation of the Multiple Sclerosis International Quality of Life questionnaire

Delirium as a presenting feature in COVID-19: Neuroinvasive infection or autoimmune encephalopathy?

Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis

Aktive Filter

Suchergebnisse filtern